Johns Hopkins Antibiotic (ABX) GuideAntibioticsAntibacterialGlycopeptide

Dalbavancin

Paul Pham, Pharm.D., Kathryn Dzintars, Pharm.D., BCPS
Dalbavancin is a topic covered in the Johns Hopkins Antibiotic (ABX) Guide.

To view the entire topic, please or purchase a subscription.

Johns Hopkins Guides provide diagnosis, management, and treatment guidance for infectious diseases, diabetes, and psychiatric conditions. Explore these free sample topics:

Johns Hopkins Guides

~~ The first section of this topic is shown below ~~

INDICATIONS

FDA

  • Treatment of acute bacterial skin and skin structure infections (ABSSSI) caused by susceptible Gram-positive organism.
    • S. aureus(including MRSA), S. pyogenes, S. agalactiae, S. dysgalactiae, S. anginosus group, E. faecalis (vancomycin-susceptible)

NON-FDA APPROVED USES

No data on the use of dalbavancin for other infections, e.g., S. aureus infections (pneumonia, bacteremia, endocarditis)

~~ To view the remaining sections of this topic, please
or purchase a subscription ~~

Last updated: April 10, 2016